BACKGROUND: Opioid misuse and abuse are growing concerns among the medical and public health communities. OBJECTIVES: To examine the prevalence of indicators for potential opioid misuse in a large, commercially insured adult population. METHODS: We adapted existing indicators developed by expert panels to include having overlapping opioid prescriptions, overlapping opioid and benzodiazepine prescriptions, long-acting/ extended release (LA/ER) opioids for acute pain,and high daily doses of opioids (>100 morphine milligram equivalents). These indicators were assessed among continuously enrolled individuals aged 18-64 years from the 2009 Truven Health MarketScan databases. Analyses were stratified by sex. RESULTS: We identified 3,391,599 eligible enrollees who received at least 1 opioid prescription. On average, enrollees obtained 3.3 opioid prescriptions, and the average annual days of supply was 47 days. Twice as many enrollees received opioid prescriptions for acute pain as for chronic pain. About a quarter of the enrollees had at least 1 indicator of either potential misuse by patients or inappropriate prescription practices by providers. About 15% of enrollees had high daily doses;7.8% had opioid overlap; and 7.9% had opioid and benzodiazepine overlap. Among those prescribed LA/ER opioids, 24.3% were treated for acute pain. Overlap indicators were more common among women. CONCLUSIONS: Our findings underscore the critical need to develop programs aimed at promoting appropriate use of opioids. Retrospective opioid utilization reviews similar to our analyses can potentially help managed care organizations and healthcare providers improve patient care and reduce the risk of adverse outcomes related to these medications.
BACKGROUND: Opioid misuse and abuse are growing concerns among the medical and public health communities. OBJECTIVES: To examine the prevalence of indicators for potential opioid misuse in a large, commercially insured adult population. METHODS: We adapted existing indicators developed by expert panels to include having overlapping opioid prescriptions, overlapping opioid and benzodiazepine prescriptions, long-acting/ extended release (LA/ER) opioids for acute pain,and high daily doses of opioids (>100 morphine milligram equivalents). These indicators were assessed among continuously enrolled individuals aged 18-64 years from the 2009 Truven Health MarketScan databases. Analyses were stratified by sex. RESULTS: We identified 3,391,599 eligible enrollees who received at least 1 opioid prescription. On average, enrollees obtained 3.3 opioid prescriptions, and the average annual days of supply was 47 days. Twice as many enrollees received opioid prescriptions for acute pain as for chronic pain. About a quarter of the enrollees had at least 1 indicator of either potential misuse by patients or inappropriate prescription practices by providers. About 15% of enrollees had high daily doses;7.8% had opioid overlap; and 7.9% had opioid and benzodiazepine overlap. Among those prescribed LA/ER opioids, 24.3% were treated for acute pain. Overlap indicators were more common among women. CONCLUSIONS: Our findings underscore the critical need to develop programs aimed at promoting appropriate use of opioids. Retrospective opioid utilization reviews similar to our analyses can potentially help managed care organizations and healthcare providers improve patient care and reduce the risk of adverse outcomes related to these medications.
Authors: Sara E Heins; Mark J Sorbero; Christopher M Jones; Andrew W Dick; Bradley D Stein Journal: Subst Use Misuse Date: 2018-01-05 Impact factor: 2.164
Authors: Pooja Lagisetty; Amy Bohnert; Jenna Goesling; Hsou Mei Hu; Breanna Travis; Kiran Lagisetty; Chad M Brummett; Michael J Englesbe; Jennifer Waljee Journal: Ann Surg Date: 2019-03-01 Impact factor: 12.969
Authors: Gerald Cochran; Jessica Rubinstein; Jennifer L Bacci; Thomas Ylioja; Ralph Tarter Journal: J Addict Med Date: 2015 Sep-Oct Impact factor: 3.702
Authors: Adam J Rose; Dana Bernson; Kenneth Kwan Ho Chui; Thomas Land; Alexander Y Walley; Marc R LaRochelle; Bradley D Stein; Thomas J Stopka Journal: J Gen Intern Med Date: 2018-06-14 Impact factor: 5.128
Authors: Calista M Harbaugh; Jay S Lee; Hsou Mei Hu; Sean Esteban McCabe; Terri Voepel-Lewis; Michael J Englesbe; Chad M Brummett; Jennifer F Waljee Journal: Pediatrics Date: 2017-12-04 Impact factor: 7.124
Authors: Lia D Delaney; Vidhya Gunaseelan; Heidi Rieck; James Michael Dupree; Brian R Hallstrom; Jennifer F Waljee Journal: J Arthroplasty Date: 2020-04-14 Impact factor: 4.757